Abstract

In May, 2018, the Director-General of WHO issued a global call to eliminate cervical cancer as a public health problem, which will involve ambitious screening and vaccination coverage targets. We aimed to assess the potential for, and timing of, cervical cancer elimination in the USA and whether this could be expedited by adopting ambitious coverage targets, using two cervical cancer simulation models. In this modelling study, we used two independently-developed cervical cancer microsimulation models-Harvard and Policy1-Cervix-to estimate changes in the incidence of human papillomavirus (HPV)-induced cervical cancer over time in the USA, including herd effects from vaccination. We compared nine alternative scenarios for prophylactic HPV vaccination and cervical screening scale-up with a status quo scenario that involved no additional interventions in the context of a threshold for cervical cancer elimination of four or fewer cases per 100 000 women-years. We also estimated the number of cervical cancer cases that could be averted between 2019 and 2100 associated with the adoption of ambitious goals for cervical cancer screening and vaccination coverage, and other potential strategies. Under status quo assumptions, the Havard and Policy1-Cervix models projected that cervical cancer incidence would decrease to less than four or fewer new cases per 100 000 women-years by the 2038 and 2046, respectively. Scaling up screening coverage to 90% in 2020, was the most effective intervention to expedite time to elimination (10-13-year reduction), averting a mean of 1400-2088 additional cases annually between 2019 and 2100. Increasing HPV vaccination coverage to 90% or vaccinating adults aged 26-45 years had relatively little effect on cervical cancer incidence. Sensitivity analysis using different population structures resulted in differences in time to elimination (range -10 years to +27 years) compared with status quo predictions. The USA is on track to eliminate cervical cancer as a public health problem in the next two to three decades. Time to elimination could be expedited by 10-13 years by achieving higher screening coverage. Targeting of underscreened and under-vaccinated women remains key to achieving cervical cancer elimination for all women. US National Cancer Institute.

Highlights

  • On May 19, 2018, the Director-General of WHO issued a global call for action towards the elimination of cervical cancer as a public health problem,[1] which will require ambitious targets for screening and vaccination coverage and scale-up of treatment for cancer and precancer

  • Our search identified three studies that estimated the time to elimination of cervical cancer globally, in Australia, and in China; we found no studies that used a comparative modelling approach or that projected the timing of elimination in the USA using current screening and vaccination coverage rates and under a range of scenarios for scaling up human papillomavirus (HPV) vaccination, screening, and follow-up for surveillance

  • Added value of this study This study assessed the potential for, and timing of, cervical cancer elimination as a public health problem in the USA, and whether this could be expedited by adopting ambitious coverage targets

Read more

Summary

Introduction

On May 19, 2018, the Director-General of WHO issued a global call for action towards the elimination of cervical cancer as a public health problem,[1] which will require ambitious targets for screening and vaccination coverage and scale-up of treatment for cancer and precancer. To achieve the target incidence, the WHO draft strategy proposes targets of 90% of girls vaccinated against human papillomavirus (HPV) by age 15 years, 70% of women screened twice in their lifetime (at 35 and 45 years of age), and 90% compliance with treatment recommendations for precancer and invasive cancer.[1]. The combined effect of HPV vaccination and HPV-based screening will probably lead to substantial declines in cervical cancer incidence in the USA in the near future; adopting ambitious coverage goals could improve the effectiveness and efficiency of current cervical cancer control efforts

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call